Polfa Tarchomin S.A.

Overview

Polfa Tarchomin S.A. is one of the oldest pharmaceutical manufacturers in Poland, specializing in the production of generic drugs and pharmaceutical substances. The company focuses on a wide range of therapeutic areas to cater to the healthcare needs domestically and internationally.

Therapeutic areas

API / Drug Master Files

Polfa Tarchomin S.A. holds 1 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ERYTHROMYCINActive1998-09-01
• ERYTHROMYCIN THIOCYANATEInactive2002-11-28
• 7-ADC ACIDInactive1997-03-04
• 6AP ACIDInactive1996-08-09
• DIAZEPAM, BULKInactive1979-02-22

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Polfa Tarchomin S.A. in our records. PharmaTek screens the full directory against live FDA enforcement data.